Anti-inflammatory modalities: Their current use in pediatric cardiac surgery in the United Kingdom and Ireland

被引:24
作者
Allen, Meredith [1 ]
Sundararajan, Santosh [1 ]
Pathan, Nazima [1 ]
Burmester, Margarita [1 ]
Macrae, Duncan [1 ]
机构
[1] Royal Brompton Hosp Pediat Intens Care, London, England
关键词
pediatric; cardiac; surgery; steroids; anti-inflammatory; bypass; SYSTEMIC INFLAMMATORY RESPONSE; MODIFIED ULTRAFILTRATION; CARDIOPULMONARY BYPASS; CLINICAL-RELEVANCE; OXYGEN DELIVERY; OPERATIONS; STEROIDS; CHILDREN; INFANTS; IMPACT;
D O I
10.1097/PCC.0b013e3181a3105d
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine the use of anti-inflammatory therapies in infants and children undergoing cardiac surgery in the United Kingdom and Ireland. Design: Questionnaire survey. Subjects: All centers that undertake pediatric cardiac surgery in the United Kingdom and Ireland. Results. All centers use at least one anti-inflammatory therapy, with 46% of centers using more than one. Both modified ultrafiltration (80%) and steroids (80%) are widely used as anti-inflammatory strategies. Among centers that use steroids, dose, preparation, and timing of steroid administered was. highly variable. Heparin-bonded circuits and aprotinin are infrequently used as anti-inflammatory techniques. Conclusion: Although anti-inflammatory interventions are believed to contribute to improved patient outcome following cardiopulmonary bypass, this survey has shown that there are still widespread variations in practice. Rather than reflecting poor clinical practice, we believe this reflects a lack of good evidence supporting clinical benefit. (Pediatr Crit Care Med 2009; 10: 341-345)
引用
收藏
页码:341 / 344
页数:4
相关论文
共 26 条
[1]   Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care [J].
Allen, ML ;
Peters, MJ ;
Goldman, A ;
Elliott, M ;
James, I ;
Callard, R ;
Klein, NJ .
CRITICAL CARE MEDICINE, 2002, 30 (05) :1140-1145
[2]  
Amanullah Muneer, 2004, Interact Cardiovasc Thorac Surg, V3, P499, DOI 10.1016/j.icvts.2004.04.001
[3]   Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease [J].
Bando, K ;
Turrentine, MW ;
Vijay, P ;
Sharp, TG ;
Sekine, Y ;
Lalone, BJ ;
Szekely, L ;
Brown, JW .
ANNALS OF THORACIC SURGERY, 1998, 66 (03) :821-827
[4]   Elimination of proinflammatory cytokines in pediatric cardiac surgery: Analysis of ultrafiltration method and filter type [J].
Berdat, PA ;
Eichenberger, E ;
Ebell, J ;
Pfammatter, JP ;
Pavlovic, M ;
Zobrist, C ;
Gygax, E ;
Nydegger, U ;
Carrel, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (06) :1688-1696
[5]   Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children [J].
Bronicki, RA ;
Backer, CL ;
Baden, HP ;
Mavroudis, C ;
Crawford, SE ;
Green, TP .
ANNALS OF THORACIC SURGERY, 2000, 69 (05) :1490-1495
[6]  
Checchia Paul A, 2005, Pediatr Crit Care Med, V6, P441, DOI 10.1097/01.PCC.0000163678.20704.C5
[7]   Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass [J].
Davies, MJ ;
Nguyen, K ;
Gaynor, JW ;
Elliott, MJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (02) :361-369
[8]   ULTRAFILTRATION AND MODIFIED ULTRAFILTRATION IN PEDIATRIC OPEN-HEART OPERATIONS [J].
ELLIOTT, MJ .
ANNALS OF THORACIC SURGERY, 1993, 56 (06) :1518-1522
[9]   A comparison of aprotinin and lysine analogues in high-risk cardiac surgery [J].
Fergusson, Dean A. ;
Hebert, Paul C. ;
Mazer, C. David ;
Fremes, Stephen ;
MacAdams, Charles ;
Murkin, John M. ;
Teoh, Kevin ;
Duke, Peter C. ;
Arellano, Ramiro ;
Blajchman, Morris A. ;
Bussieres, Jean S. ;
Cote, Dany ;
Karski, Jacek ;
Martineau, Raymond ;
Robblee, James A. ;
Rodger, Marc ;
Wells, George ;
Clinch, Jennifer ;
Pretorius, Roanda .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22) :2319-2331
[10]  
Freedom RM, 2000, CIRCULATION, V102, P58